SAM
CLLS

Stansberry Asset Management’s Cellectis CLLS Stock Holding History

Stansberry Asset Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-110,245
Closed -$3.11M – 83
2018
Q3 		$3.11M Buy
110,245
+5,768
+6% +$166K 0.87% 35
2018
Q2 		$2.96M Buy
+104,477
New +$3.11M 0.98% 36

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stansberry Asset Management's CLLS Position: Q4 2018 in Review

Stansberry Asset Management sold out of Cellectis (CLLS) in Q4 2018, closing a stake of 110,245 shares — an estimated $3.11M sold.

Stansberry Asset Management first reported a position in CLLS in Q2 2018 and held it in 2 quarters. The position peaked at $3.11M in Q3 2018. 65 funds tracked by Wall St. Rank hold CLLS as of Q4 2018.

  • Stansberry Asset Management reported no remaining Cellectis position as of Q4 2018 after selling out during the quarter.
  • Stansberry Asset Management sold 110,245 Cellectis shares in Q4 2018, an estimated $3.11M.
  • Stansberry Asset Management first reported a position in Cellectis in Q2 2018 and held it in 2 quarters.
  • Stansberry Asset Management's Cellectis position peaked at $3.11M in Q3 2018.
  • 65 funds tracked by Wall St. Rank held Cellectis as of Q4 2018.

Based on Stansberry Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.